Newsfeed

Bei diesem Bereich handelt es sich um eine mögliche Darstellungsform der Integration von Nachrichtenquellen mit Bezug zu börsennotierten Unternehmen.
Als Präsentationsebene fungiert ein Template, dass an Kurznachrichtenservices angelehnt ist, bei dem sich Nutzer einen schnellen Überblick über aktuelle Nachrichten verschaffen können. Die Detailansichten ermöglichen bei Interesse weitergehende Recherchen.

Dieser Newsfeed ist eine Zusammenstellung aktueller Nachrichten, die aus Direktanbindungen von TopTier NewsWire-Services mit Bezug zu börsennotierten Unternehmen stammen. Dieser Feed hier dient ausschließlich Demonstrationszwecken. Sektoren-spezifische Nachrichten, Public Relations sowie Produktinformationen können über die GICS Portale > Bereich Sektor-Intelligence abgerufen werden.

US2183521028
Filter zurücksetzen
Do you already know our new terminal view? Click here.
FIGI: BBG000BF8JD9
CORT
Corcept Therapeutics Inc
GICS: Health Care · SECTOR: EQTY · SUB-SECTOR: Biotechnology · THEMEFOLIO: $HLTH
NAME
Corcept Therapeutics Inc
ISIN
US2183521028
TICKER
CORT
MIC
XNAS
REUTERS
CORT.OQ
BLOOMBERG
CORT US
Do., 19.03.2026       Corcept Therapeutics
US2183521028

New York, New York--(Newsfile Corp. - March 18, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Corcept Therapeutics Incorporated (NASDAQ: CORT) between October 31, 2024 and December 30, 2025, inclusive (the "Class Period"), of the important April 21, 2026 lead plaintiff deadline.SO WHAT: I...
Zur Nachricht
Corcept Therapeutics
Charts & Research Termsheets Terminal
Permalink
Mi., 18.03.2026       Corcept Therapeutics
US2183521028

SAN DIEGO, March 18, 2026 /PRNewswire/ -- Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Corcept Therapeutics Incorporated (NASDAQ: CORT) common stock between October 31, 2024 and December 30, 2025. Corcept is a pharmaceutical company focused on the development of medic...
Zur Nachricht
Corcept Therapeutics
Charts & Research Termsheets Terminal
Permalink
Mi., 18.03.2026       Corcept Therapeutics
US2183521028

Lawsuit Alleges Management Concealed Repeated FDA Warnings Regarding Insufficient Data While Touting Pipeline Readiness; Firm Reminds Investors of April 21 DeadlineSAN FRANCISCO, March 18, 2026 /PRNewswire/ -- National shareholder rights law firm Hagens Berman reminds investors in Corcept Therapeutics Incorporated (NASDAQ: CORT) that the deadline...
Zur Nachricht
Corcept Therapeutics
Charts & Research Termsheets Terminal
Permalink
Mi., 18.03.2026       Corcept Therapeutics
US2183521028

NEW YORK, March 18, 2026 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Corcept Therapeutics Incorporated ("Corcept Therapeutics Incorporated" or the "Company") (NASDAQ: CORT) of a class action securities lawsuit. CLA...
Zur Nachricht
Corcept Therapeutics
Charts & Research Termsheets Terminal
Permalink
Mi., 18.03.2026       Corcept Therapeutics
US2183521028

New York, New York--(Newsfile Corp. - March 17, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Corcept Therapeutics Incorporated (NASDAQ: CORT) between October 31, 2024 and December 30, 2025, inclusive (the "Class Period"), of the important April 21, 2026 lead plaintiff deadline.SO WHAT: I...
Zur Nachricht
Corcept Therapeutics
Charts & Research Termsheets Terminal
Permalink
Di., 17.03.2026       Corcept Therapeutics
US2183521028

LOS ANGELES, March 17, 2026 /PRNewswire/ -- Glancy Prongay Wolke & Rotter LLP announces that investors with losses have opportunity to lead the securities fraud class action lawsuit against Corcept Therapeutics Incorporated ("Corcept" or the "Company") (NASDAQ: CORT)....
Zur Nachricht
Corcept Therapeutics
Charts & Research Termsheets Terminal
Permalink
Di., 17.03.2026       Corcept Therapeutics
US2183521028

NEW YORK, March 17, 2026 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Corcept Therapeutics Incorporated (NASDAQ: CORT). Shareholders who purchased shares of CORT during the class period listed are...
Zur Nachricht
Corcept Therapeutics
Charts & Research Termsheets Terminal
Permalink
Di., 17.03.2026       Corcept Therapeutics
US2183521028

New York, New York--(Newsfile Corp. - March 16, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Corcept Therapeutics Incorporated (NASDAQ: CORT) between October 31, 2024 and December 30, 2025, inclusive (the "Class Period"), of the important April 21, 2026 lead plaintiff deadline.SO WHAT: If you...
Zur Nachricht
Corcept Therapeutics
Charts & Research Termsheets Terminal
Permalink
Mo., 16.03.2026       Corcept Therapeutics
US2183521028

Lawsuit Alleges Management Concealed Repeated FDA Warnings Regarding Insufficient Data While Touting Pipeline Readiness; Firm Reminds Investors of April 21 DeadlineSAN FRANCISCO, March 16, 2026 /PRNewswire/ -- National shareholder rights law firm Hagens Berman reminds investors in Corcept Therapeutics Incorporated (NASDAQ: CORT) that the deadline...
Zur Nachricht
Corcept Therapeutics
Charts & Research Termsheets Terminal
Permalink
Mo., 16.03.2026       Corcept Therapeutics
US2183521028

LOS ANGELES, March 16, 2026 /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against Corcept Therapeutics Incorporated ("Corcept" or "the Company") (NASDAQ: CORT) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commissi...
Zur Nachricht
Corcept Therapeutics
Charts & Research Termsheets Terminal
Permalink
Silent Ad
Mo., 16.03.2026       Corcept Therapeutics
US2183521028

LOS ANGELES, March 16, 2026 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Corcept Therapeutics Incorporated ("Corcept" or "the Company") (NASDAQ: CORT) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated there...
Zur Nachricht
Corcept Therapeutics
Charts & Research Termsheets Terminal
Permalink
Mo., 16.03.2026       Corcept Therapeutics
US2183521028

NEW YORK, March 16, 2026 /PRNewswire/ --  Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Corcept Therapeutics Incorporated (NASDAQ: CORT) between October 31, 2024 and December 30, 2025, i...
Zur Nachricht
Corcept Therapeutics
Charts & Research Termsheets Terminal
Permalink
Sa., 14.03.2026       Corcept Therapeutics
US2183521028

NEW YORK and NEW ORLEANS, March 13, 2026 /PRNewswire/ -- Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors with substantial losses that they have until April 21, 2026 to file lead plaintiff applications in a securities class action lawsuit against Corcept Therapeutics I...
Zur Nachricht
Corcept Therapeutics
Charts & Research Termsheets Terminal
Permalink
Do., 12.03.2026       Corcept Therapeutics
US2183521028

New York, New York--(Newsfile Corp. - March 12, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Corcept Therapeutics Incorporated (NASDAQ: CORT) between October 31, 2024 and December 30, 2025, inclusive (the "Class Period"), of the important April 21, 2026 lead plaintiff deadline.SO WHAT: I...
Zur Nachricht
Corcept Therapeutics
Charts & Research Termsheets Terminal
Permalink
Do., 12.03.2026       Corcept Therapeutics
US2183521028

CORT Investors with Losses Encouraged to Contact Hagens BermanSAN FRANCISCO, March 12, 2026 /PRNewswire/ -- National shareholder rights law firm Hagens Berman is notifying investors that a securities class action lawsuit has been filed against Corcept Therapeutics Inc. (NASDAQ: CORT) and certain of its top executives. The lawsuit, Allegheny County...
Zur Nachricht
Corcept Therapeutics
Charts & Research Termsheets Terminal
Permalink
Do., 12.03.2026       Corcept Therapeutics
US2183521028

NEW YORK, March 12, 2026 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Corcept Therapeutics Incorporated ("Corcept" or the "Company") (NASDAQ: CORT).   Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquir...
Zur Nachricht
Corcept Therapeutics
Charts & Research Termsheets Terminal
Permalink
Do., 12.03.2026       Corcept Therapeutics
US2183521028

LOS ANGELES, March 12, 2026 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Corcept Therapeutics Incorporated ("Corcept" or "the Company") (NASDAQ: CORT) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated there...
Zur Nachricht
Corcept Therapeutics
Charts & Research Termsheets Terminal
Permalink
Do., 12.03.2026       Corcept Therapeutics
US2183521028

LOS ANGELES, March 12, 2026 /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against Corcept Therapeutics Incorporated ("Corcept" or "the Company") (NASDAQ: CORT) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commissi...
Zur Nachricht
Corcept Therapeutics
Charts & Research Termsheets Terminal
Permalink
Mi., 11.03.2026       Corcept Therapeutics
US2183521028

New York, New York--(Newsfile Corp. - March 11, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Corcept Therapeutics Incorporated (NASDAQ: CORT) between October 31, 2024 and December 30, 2025, inclusive (the "Class Period"), of the important April 21, 2026 lead plaintiff deadline.SO WHAT: If you...
Zur Nachricht
Corcept Therapeutics
Charts & Research Termsheets Terminal
Permalink
Mi., 11.03.2026       Corcept Therapeutics
US2183521028

NEW YORK, March 11, 2026 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Corcept Therapeutics Incorporated ("Corcept Therapeutics Incorporated" or the "Company") (NASDAQ: CORT) of a class action securities lawsuit. CLA...
Zur Nachricht
Corcept Therapeutics
Charts & Research Termsheets Terminal
Permalink
Silent Ad
Mi., 11.03.2026       Corcept Therapeutics
US2183521028

NEW YORK, March 10, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Corcept Therapeutics Incorporated (NASDAQ: CORT) between October 31, 2024 and December 30, 2025, in...
Zur Nachricht
Corcept Therapeutics
Charts & Research Termsheets Terminal
Permalink
Di., 10.03.2026       Corcept Therapeutics
US2183521028

BENSALEM, Pa., March 10, 2026 /PRNewswire/ -- The Law Offices of Howard G. Smith announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against Corcept Therapeutics Incorporated ("Corcept" or the "Company") (NASDAQ: CORT). IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN CORCEPT THERAPEUTIC...
Zur Nachricht
Corcept Therapeutics
Charts & Research Termsheets Terminal
Permalink
Di., 10.03.2026       Corcept Therapeutics
US2183521028

Kirby McInerney LLP reminds Corcept Therapeutics Incorporated (“Corcept” or the “Company”) (NASDAQ:CORT) investors of the April 21, 2026 deadline to seek the role of lead plaintiff in a pending federal securities class action. Courts do not consider applications filed after this deadline. The lead plaintiff oversees the litigation on behalf of the...
Zur Nachricht
Corcept Therapeutics
Charts & Research Termsheets Terminal
Permalink
Di., 10.03.2026       Corcept Therapeutics
US2183521028

CORT Investors with Losses Encouraged to Contact the FirmSAN FRANCISCO, March 10, 2026 /PRNewswire/ -- National shareholder rights law firm Hagens Berman is notifying investors that a securities class action lawsuit has been filed against Corcept Therapeutics Inc. (NASDAQ: CORT) and certain of its top executives. The lawsuit, Allegheny County Empl...
Zur Nachricht
Corcept Therapeutics
Charts & Research Termsheets Terminal
Permalink
Di., 10.03.2026       Corcept Therapeutics
US2183521028

NEW YORK, March 10, 2026 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Corcept Therapeutics Incorporated (NASDAQ: CORT). Shareholders who purchased shares of CORT during the class period listed are...
Zur Nachricht
Corcept Therapeutics
Charts & Research Termsheets Terminal
Permalink
Di., 10.03.2026       Corcept Therapeutics
US2183521028

New York, New York--(Newsfile Corp. - March 9, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Corcept Therapeutics Incorporated (NASDAQ: CORT) between October 31, 2024 and December 30, 2025, inclusive (the "Class Period"), of the important April 21, 2026 lead plaintiff deadline.SO WHAT: If you...
Zur Nachricht
Corcept Therapeutics
Charts & Research Termsheets Terminal
Permalink
Mo., 09.03.2026       Corcept Therapeutics
US2183521028

LOS ANGELES, March 9, 2026 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with losses related to Corcept Therapeutics Incorporated ("Corcept" or the "Company") (NASDAQ: CORT) have opportunity to lead the securities fraud class action lawsuit....
Zur Nachricht
Corcept Therapeutics
Charts & Research Termsheets Terminal
Permalink
Mo., 09.03.2026       Corcept Therapeutics
US2183521028

LOS ANGELES, March 9, 2026 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Corcept Therapeutics Incorporated ("Corcept" or "the Company") (NASDAQ: CORT) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereu...
Zur Nachricht
Corcept Therapeutics
Charts & Research Termsheets Terminal
Permalink
Mo., 09.03.2026       Corcept Therapeutics
US2183521028

LOS ANGELES, March 9, 2026 /PRNewswire/ --  The DJS Law Group  reminds investors of a class action lawsuit against Corcept Therapeutics Incorporated ("Corcept " or "the Company") (NASDAQ: CORT ) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commi...
Zur Nachricht
Corcept Therapeutics
Charts & Research Termsheets Terminal
Permalink
So., 08.03.2026       Corcept Therapeutics
US2183521028

New York, New York--(Newsfile Corp. - March 7, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Corcept Therapeutics Incorporated (NASDAQ: CORT) between October 31, 2024 and December 30, 2025, inclusive (the "Class Period"), of the important April 21, 2026 lead plaintiff deadline.SO WHAT: If...
Zur Nachricht
Corcept Therapeutics
Charts & Research Termsheets Terminal
Permalink
Sa., 07.03.2026       Corcept Therapeutics
US2183521028

NEW ORLEANS, March 6, 2026 /PRNewswire/ -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until April 21, 2026 to file lead plaintiff applications in a securities class action lawsuit against Corcept Therapeutics Incorporated (NasdaqCM: CORT) ("Corcept" or the "Company"), if they purchased or otherwise acquir...
Zur Nachricht
Corcept Therapeutics
Charts & Research Termsheets Terminal
Permalink
Sa., 07.03.2026       Corcept Therapeutics
US2183521028

New York, New York--(Newsfile Corp. - March 6, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Corcept Therapeutics Incorporated (NASDAQ: CORT) between October 31, 2024 and December 30, 2025, inclusive (the "Class Period"), of the important April 21, 2026 lead plaintiff deadline.SO WHAT: If you...
Zur Nachricht
Corcept Therapeutics
Charts & Research Termsheets Terminal
Permalink
Fr., 06.03.2026       Corcept Therapeutics
US2183521028

NEW YORK, March 5, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Corcept Therapeutics Incorporated (NASDAQ: CORT) between October 31, 2024 and December 30, 2025, inc...
Zur Nachricht
Corcept Therapeutics
Charts & Research Termsheets Terminal
Permalink
Do., 05.03.2026       Corcept Therapeutics
US2183521028

NEW YORK, March 5, 2026 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Corcept Therapeutics Incorporated ("Corcept" or the "Company") (NASDAQ: CORT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire b...
Zur Nachricht
Corcept Therapeutics
Charts & Research Termsheets Terminal
Permalink
Do., 05.03.2026       Corcept Therapeutics
US2183521028

Lawsuit Alleges Corcept Ignored Repeated FDA Warnings Against Filing Relacorilant NDA; Stock Plunged 50% on Revealed "Evidence Gaps"SAN FRANCISCO, March 5, 2026 /PRNewswire/ -- National shareholder rights law firm Hagens Berman is notifying investors that a securities class action lawsuit has been filed against Corcept Therapeutics Inc. (NASDAQ: C...
Zur Nachricht
Corcept Therapeutics
Charts & Research Termsheets Terminal
Permalink
Do., 05.03.2026       Corcept Therapeutics
US2183521028

LOS ANGELES, March 5, 2026 /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against Corcept Therapeutics Incorporated ("Corcept " or "the Company") (NASDAQ: CORT ) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commiss...
Zur Nachricht
Corcept Therapeutics
Charts & Research Termsheets Terminal
Permalink
Do., 05.03.2026       Corcept Therapeutics
US2183521028

LOS ANGELES, March 5, 2026 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Corcept Therapeutics Incorporated ("Corcept" or "the Company") (NASDAQ: CORT) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereu...
Zur Nachricht
Corcept Therapeutics
Charts & Research Termsheets Terminal
Permalink
Do., 05.03.2026       Corcept Therapeutics
US2183521028

New York, New York--(Newsfile Corp. - March 4, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Corcept Therapeutics Incorporated (NASDAQ: CORT) between October 31, 2024 and December 30, 2025, inclusive (the "Class Period"), of the important April 21, 2026 lead plaintiff deadline.SO WHAT: If you...
Zur Nachricht
Corcept Therapeutics
Charts & Research Termsheets Terminal
Permalink
Mi., 04.03.2026       Corcept Therapeutics
US2183521028

The Law Offices of Frank R. Cruz announces that a class action lawsuit has been filed on behalf of shareholders who purchased or otherwise acquired Corcept Therapeutics Incorporated (“Corcept” or the “Company”) (NASDAQ: CORT) common stock between October 31, 2024 and December 30, 2025, inclusive (the “Class Period”). Corcept investors have until A...
Zur Nachricht
Corcept Therapeutics
Charts & Research Termsheets Terminal
Permalink
Mi., 04.03.2026       Corcept Therapeutics
US2183521028

NEW YORK, March 4, 2026 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Corcept Therapeutics Incorporated ("Corcept Therapeutics Incorporated" or the "Company") (NASDAQ: CORT) of a class action securities lawsuit. CLAS...
Zur Nachricht
Corcept Therapeutics
Charts & Research Termsheets Terminal
Permalink
Di., 03.03.2026       Corcept Therapeutics
US2183521028

New York, New York--(Newsfile Corp. - March 3, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Corcept Therapeutics Incorporated (NASDAQ: CORT) between October 31, 2024 and December 30, 2025, inclusive (the "Class Period"), of the important April 21, 2026 lead plaintiff deadline.SO WHAT: If...
Zur Nachricht
Corcept Therapeutics
Charts & Research Termsheets Terminal
Permalink
Di., 03.03.2026       Corcept Therapeutics
US2183521028

Glancy Prongay Wolke & Rotter LLP reminds investors of the upcoming April 21, 2026 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Corcept Therapeutics Incorporated (“Corcept” or the “Company”) (NASDAQ: CORT) common stock between October 31, 2024 and December 30, 202...
Zur Nachricht
Corcept Therapeutics
Charts & Research Termsheets Terminal
Permalink
Di., 03.03.2026       Corcept Therapeutics
US2183521028

Lawsuit Alleges Corcept Ignored Repeated FDA Warnings Against Filing Relacorilant NDA; Stock Plunged 50% on Revealed "Evidence Gaps"SAN FRANCISCO, March 3, 2026 /PRNewswire/ -- National shareholder rights law firm Hagens Berman is notifying investors that a securities class action lawsuit has been filed against Corcept Therapeutics Inc. (NASDAQ: C...
Zur Nachricht
Corcept Therapeutics
Charts & Research Termsheets Terminal
Permalink
Di., 03.03.2026       Corcept Therapeutics
US2183521028

NEW YORK, March 3, 2026 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Corcept Therapeutics Incorporated (NASDAQ: CORT). Shareholders who purchased shares of CORT during the class period listed are e...
Zur Nachricht
Corcept Therapeutics
Charts & Research Termsheets Terminal
Permalink
Di., 03.03.2026       Corcept Therapeutics
US2183521028

NEW YORK, March 2, 2026 /PRNewswire/ --  Why: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of common stock of Corcept Therapeutics Incorporated (NASDAQ: CORT) between Octo...
Zur Nachricht
Corcept Therapeutics
Charts & Research Termsheets Terminal
Permalink
Mo., 02.03.2026       Corcept Therapeutics
US2183521028

Law Offices of Howard G. Smith reminds investors of the upcoming April 21, 2026 deadline to file a lead plaintiff motion in the case filed on behalf of investors who purchased Corcept Therapeutics Incorporated (“Corcept” or the “Company”) (NASDAQ: CORT) common stock between October 31, 2024 and December 30, 2025, inclusive (the “Class Period”)....
Zur Nachricht
Corcept Therapeutics
Charts & Research Termsheets Terminal
Permalink
Mo., 02.03.2026       Corcept Therapeutics
US2183521028

LOS ANGELES, March 2, 2026 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Corcept Therapeutics Incorporated ("Corcept" or "the Company") (NASDAQ: CORT) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereu...
Zur Nachricht
Corcept Therapeutics
Charts & Research Termsheets Terminal
Permalink
Mo., 02.03.2026       Corcept Therapeutics
US2183521028

LOS ANGELES, March 2, 2026 /PRNewswire/ -- The DJS Law Group  reminds investors of a class action lawsuit against  Corcept Therapeutics Incorporated ("Corcept " or "the Company") (NASDAQ: CORT ) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commi...
Zur Nachricht
Corcept Therapeutics
Charts & Research Termsheets Terminal
Permalink
So., 01.03.2026       Corcept Therapeutics
US2183521028

New York, New York--(Newsfile Corp. - March 1, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of common stock of Corcept Therapeutics Incorporated (NASDAQ: CORT) between October 31, 2024 and December 30, 2025, inclusive (the "Class Period"). A class action lawsuit has already...
Zur Nachricht
Corcept Therapeutics
Charts & Research Termsheets Terminal
Permalink
Sa., 28.02.2026       Corcept Therapeutics
US2183521028

NEW YORK and NEW ORLEANS, Feb. 27, 2026 /PRNewswire/ -- Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors with substantial losses that they have until April 21, 2026 to file lead plaintiff applications in a securities class action lawsuit against Corcept Therapeutics In...
Zur Nachricht
Corcept Therapeutics
Charts & Research Termsheets Terminal
Permalink